News
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
11 Apr 24
Biotech, News, Health Care, General
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Mar 24
Movers
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer's and Parkinson's Diseases at AD/PD 2024 International Conference
8 Mar 24
News
Athira Pharma Announces Publication In Frontiers In Neuroscience Highlighting Therapeutic Potential Of ATH-1105 In Amyotrophic Lateral Sclerosis
8 Feb 24
Biotech, News, General
Press releases
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
15 Apr 24
News, Management, Press Releases
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease
11 Apr 24
Health Care, Press Releases
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer's and Parkinson's Diseases at AD/PD™ 2024 International Conference
8 Mar 24
Biotech, News, Health Care, Press Releases, General
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
8 Feb 24
Biotech, Analyst Ratings, Press Releases, General